The information provided is for convenience only. It is not investment advice or a recommendation, it does not constitute a solicitation to buy or sell securities, and it may not be relied upon in considering an investment in a Cardone fund. Past performance is no guarantee of future results. Any historical returns expected returns or probability projections may not reflect actual future performance. All securities involve risk and may result in partial or total loss. Investment in Cardone funds is available only to independently verified “accredited investors” through an offering made in accordance with Rule 506(c) under Regulation D of the Securities Act of 1933. Before investing in any Cardone fund, prospective investors should consider carefully the investment objective(s), risks, arches, and expenses. While the data we use from third parties is believed to be reliable, we cannot ensure the accuracy or completeness of the data provided. Cardone Capital does not provide legal or tax advice. Prospective investors should consult with a tax or legal adviser before making any investment decision.

The Business of Sports Medicine

In this Show

“Interview with Brad Layzell – CEO of PX3 Sports Sciences PX3 is an innovative breathing orthotic that has been in development in multiple sectors, including sports medicine/injury prevention, wellness, fitness, neurosciences, sleep and human performance sectors. PX3 orthotics are worn by many professional and elite level athletes. Brad discusses PX3 company development from an entrepreneur perspective and the challenges associated with developing a disruptive technology. PX3 products are positioned for growth and significant commercialization and sales with a sound R&D platform and IP portfolio.”

(Visited 47 times, 1 visits today)